MATTHEW CLARDY: Open Payments
NPI 1962282509 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 27 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $181 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $141 |
| Vanda Pharmaceuticals Inc. | 1 | $88 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| ABBVIE INC. | 1 | $20 |
Products named: REXULTI, FANAPT, Auvelity, ARISTADA, UZEDY, COBENFY, VRAYLAR.
Industry payments across IN — which companies pay providers there.
